NeOnc Technologies, Inc.
Recorded under 3 name spellings.
When these terms end
Fee deadlines
No maintenance fee falls due on this company's record before Nov 22, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
No patent on this record is in force and held under this name now.
Sources and methods
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
7 pending · 9 abandoned · 14 no status recorded
Showing 1 to 10 of 30, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/946,291 | Pharmaceutical Compositions Comprising Perillyl Alcohol Derivatives | Nov 13, 2024 | Pending |
| 18/190,643 | Mar 27, 2023 | No status recorded | |
| 18/150,933 | Pharmaceutical Compositions Comprising Poh Derivatives and Methods of Use | Jan 6, 2023 | Abandoned |
| 17/943,567 | Pharmaceutical Compositions Comprising Perillyl Alcohol Derivatives | Sep 13, 2022 | Abandoned |
| 18/557,650 | Use of Perillyl Alcohol to Enhance Levo-Dopa Delivery | Apr 28, 2022 | Pending |
| 17/573,693 | Pharmaceutical Compositions Comprising Poh Derivatives | Jan 12, 2022 | Abandoned |
| 18/251,839 | Treatment of Recurrent Gioblastoma with Perillyl Alcohol | Nov 12, 2021 | Pending |
| 18/248,733 | Combination of Poh and Remdesivir for Treatment of CNS Infections | Oct 18, 2021 | Pending |
| 17/390,292 | Methods of Treating Cancer Using Compositions Comprising Perillyl Alcohol Derivative | Jul 30, 2021 | Abandoned |
| 18/001,082 | Compositions and Methods for Delivering Polynucleotides | Jun 8, 2021 | Pending |